Search Results - "FAVALORO, J"
-
1
Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia
Published in International journal of laboratory hematology (01-08-2021)“…COVID‐19 (coronavirus disease 2019) represents a pandemic, and several vaccines have been produced to prevent infection and/or severe sequelae associated with…”
Get full text
Journal Article -
2
Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests
Published in American journal of hematology (01-01-2020)“…Coagulation testing underpins the investigation of hemostasis and/or monitoring of anticoagulation therapy for prevention and/or treatment of thrombosis…”
Get full text
Journal Article -
3
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History
Published in Seminars in thrombosis and hemostasis (01-02-2024)“…There is no certainty in change, other than change is certain. As celebrates 50 years of publication, I felt it appropriate to reflect on my own 40-year plus…”
Get more information
Journal Article -
4
The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA)
Published in American journal of hematology (01-11-2019)“…Lupus anticoagulants (LAs) are a laboratory representation of the clinical syndrome of antiphospholipid syndrome (APS), and can also arise in other…”
Get full text
Journal Article -
5
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
Published in Seminars in thrombosis and hemostasis (01-02-2022)“…Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential prothrombotic risk in several autoimmune conditions, most notably…”
Get more information
Journal Article -
6
Coronavirus Disease 2019–Associated Coagulopathy
Published in Mayo Clinic proceedings (01-01-2021)“…Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently found to suffer from both arterial and venous thrombotic events due…”
Get full text
Journal Article -
7
Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)
Published in Clinical chemistry and laboratory medicine (26-01-2022)“…Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In…”
Get more information
Journal Article -
8
Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges
Published in Current drug metabolism (01-07-2017)“…The Direct Oral Anticoagulants (DOACs) represent a new generation of antithrombotic agents, providing direct inhibition of either thrombin (factor IIa; FIIa)…”
Get more information
Journal Article -
9
The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on fibrinolysis
Published in Journal of thrombosis and haemostasis (01-09-2020)Get full text
Journal Article -
10
Autoimmune Diseases Affecting Hemostasis: A Narrative Review
Published in International journal of molecular sciences (25-11-2022)“…Hemostasis reflects a homeostatic mechanism that aims to balance out pro-coagulant and anti-coagulant forces to maintain blood flow within the circulation…”
Get full text
Journal Article -
11
Editorial Compilation-XIII
Published in Seminars in thrombosis and hemostasis (01-07-2023)Get more information
Journal Article -
12
Towards improved diagnosis of von Willebrand disease: Comparative evaluations of several automated von Willebrand factor antigen and activity assays
Published in Thrombosis research (01-12-2014)“…Abstract Introduction von Willebrand disease (VWD) is reportedly the most common bleeding disorder and arises from deficiency and/or defects of von Willebrand…”
Get full text
Journal Article -
13
Laboratory tests used to help diagnose von Willebrand disease: an update
Published in Pathology (01-06-2016)“…von Willebrand disease (VWD) is due to quantitative deficiencies and/or qualitative defects in von Willebrand factor (VWF), and is reportedly the most common…”
Get full text
Journal Article -
14
Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives
Published in Pathology (01-04-2019)“…We and others have previously highlighted the potential problems with testing of lupus anticoagulants (LA) in patients on anticoagulant therapy, including most…”
Get full text
Journal Article -
15
Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
Published in Research and practice in thrombosis and haemostasis (01-02-2022)“…Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or…”
Get full text
Journal Article -
16
-
17
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples
Published in Pathology (01-01-2016)“…The direct oral anticoagulants (DOACs), now including dabigatran, apixaban and rivaroxaban, have given clinicians alternative options to low molecular weight…”
Get full text
Journal Article -
18
-
19
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia
Published in Seminars in thrombosis and hemostasis (01-07-2023)“…Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high…”
Get more information
Journal Article -
20
Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
Published in Research and practice in thrombosis and haemostasis (01-08-2020)“…14 The clinical utility of one VWF test method, multimer analysis, is featured in this issue of the journal. 15 Considered essential for VWD diagnosis and…”
Get full text
Journal Article